Literature DB >> 8528558

Effects of 5-HT receptor agonists on depolarization-induced [3H]-noradrenaline release in rabbit hippocampus and human neocortex.

C Allgaier1, P Warnke, A P Stangl, T J Feuerstein.   

Abstract

1. The present study attempted to determine whether noradrenaline (NA) release in rabbit hippocampus and human neocortex is modulated by presynaptic 5-hydroxytryptamine (5-HT) receptors. 2. Slices of rabbit hippocampus and human neocortex, loaded with [3H]-noradrenaline ([3H]-NA) were superfused and the effects of 5-hydroxytryptamine (5-HT) receptor ligands on electrically evoked [3H]-NA release were investigated. 3. In rabbit hippocampus, 5-HT, 5-carboxamidotryptamine (5-CT; 32 microM) and 2-CH3-5-HT (32 microM) increased [3H]-NA release elicited with 360 pulses/3 Hz. Facilitation of transmitter release was not influenced by the 5-HT3 receptor antagonist, tropisetron but was prevented by the alpha 2-adrenoceptor antagonist, rauwolscine. When autoinhibition was avoided by stimulating the tissue with 4 pulses/100 Hz (pseudo-one pulse-(POP) stimulation), 2-CH3-5-HT decreased evoked transmitter release, whereas 5-HT and 5-CT had no effect. Inhibition caused by 2-CH3-5-HT was not affected by tropisetron but counteracted by the alpha 2-adrenoceptor ligands, clonidine and rauwolscine. Inhibition caused by clonidine was diminished in the presence of 5-CT or 2-CH3-5-HT. 4. In human neocortex, [3H]-NA release elicited with 360 pulses/3 Hz was increased by 10 microM 5-HT and 32 microM 5-CT, whereas 2-CH3-5-HT was ineffective. [3H]-NA release evoked with a modified POP stimulation (2 bursts of 4 pulses/100 Hz, 3.5 min apart) was not affected by 2-CH3-5-HT or 5-CT. 5. The present results indicate that 5-HT, 2-CH3-5-HT and 5-CT can act on presynaptic alpha 2-autoreceptors as partial agonists (2-CH3-5-HT; in rabbit hippocampal tissue) or antagonists (5-HT and 5-CT; in tissue of rabbit hippocampus and human neocortex). Furthermore the existence of autoinhibition dictates whether these drugs cause facilitation of release, inhibition or have no effect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8528558      PMCID: PMC1909076          DOI: 10.1111/j.1476-5381.1995.tb16661.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Mutual interaction between presynaptic alpha 2-adrenoceptors and 5-HT1B receptors on the sympathetic nerve terminals of the rat inferior vena cava.

Authors:  G J Molderings; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-05       Impact factor: 3.000

2.  Antagonistic properties of RU 24969, a preferential 5-HT1 receptor agonist, at presynaptic alpha 2-adrenoceptors of central and peripheral neurones.

Authors:  E Schlicker; G Molderings; R Betz; M Göthert
Journal:  Pharmacol Toxicol       Date:  1988-10

3.  Presynaptic alpha 2-adrenoceptor, opioid kappa-receptor and adenosine A1-receptor interactions on noradrenaline release in rabbit brain cortex.

Authors:  N Limberger; L Späth; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

4.  Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein via presynaptic 5-HT receptors similar to the 5-HT 1D subtype.

Authors:  G J Molderings; K Werner; J Likungu; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

5.  Inhibition of norepinephrine and acetylcholine release from human neocortex by omega-conotoxin GVIA.

Authors:  T J Feuerstein; D J Dooley; W Seeger
Journal:  J Pharmacol Exp Ther       Date:  1990-02       Impact factor: 4.030

6.  Presynaptic kappa-opioid receptors on noradrenergic nerve terminals couple to G proteins and interact with the alpha 2-adrenoceptors.

Authors:  C Allgaier; B Daschmann; J Sieverling; G Hertting
Journal:  J Neurochem       Date:  1989-11       Impact factor: 5.372

7.  Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava.

Authors:  G J Molderings; K Fink; E Schlicker; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

8.  Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices.

Authors:  P Blandina; J Goldfarb; J Walcott; J P Green
Journal:  J Pharmacol Exp Ther       Date:  1991-01       Impact factor: 4.030

9.  Inhibition of noradrenaline release in the pig coronary artery via a novel serotonin receptor.

Authors:  G J Molderings; M Göthert; K Fink; E Roth; E Schlicker
Journal:  Eur J Pharmacol       Date:  1989-05-19       Impact factor: 4.432

10.  Presynaptic autoinhibition of central noradrenaline release in vitro: operational characteristics and effects of drugs acting at alpha-2 adrenoceptors in the presence of uptake inhibition.

Authors:  B Valenta; H Drobny; E A Singer
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

View more
  1 in total

1.  Cholinergic enhancement of episodic memory in healthy young adults.

Authors:  Georg Grön; Matthias Kirstein; Axel Thielscher; Matthias W Riepe; Manfred Spitzer
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.